Reed Elsevier NV Press Releases

Get ENL Alerts
*Delayed - data as of Sep. 19, 2014 9:53 ET  -  Find a broker to begin trading ENL now
Exchange: NYSE
Industry: Consumer Services
Community Rating:
View:    ENL Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock
9/16/2014 4:45:00 PM - PR Newswire

Elsevier Publishes New Books on Bone and Endocrine Disease
9/11/2014 4:00:00 AM - Market Wire

Top-Line Data Show the Investigational TOPAS™ System Improves Fecal Incontinence in Women
9/8/2014 4:30:00 PM - PR Newswire

Endo to Present at Morgan Stanley Global Healthcare Conference 2014
9/8/2014 12:00:00 PM - PR Newswire

Endo announces launch of Authorized Generic of FORTESTA® Gel
9/8/2014 7:30:00 AM - PR Newswire

Elsevier Publishes New Chemical Engineering Content
9/3/2014 4:00:00 AM - Market Wire

Endo completes acquisition of DAVA Pharmaceuticals
8/6/2014 5:00:00 PM - PR Newswire

Endo Reports Second Quarter Financial Results
7/31/2014 6:30:00 AM - PR Newswire

Endo appoints Shane M. Cooke to Board of Directors
7/30/2014 4:15:00 PM - PR Newswire

Endo completes acquisition of Grupo Farmaceutico Somar®
7/24/2014 4:15:00 PM - PR Newswire

Endo to Announce Second Quarter 2014 Financial Results on July 31, 2014
7/15/2014 9:00:00 AM - PR Newswire

ADDING MULTIMEDIA Reed Tech Strengthens Line of LexisNexis Intellectual Property Solutions by Acquiring PatentCore, an Innovator in Patent Data Analytics
7/8/2014 9:05:00 AM - Business Wire

Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain
7/7/2014 7:00:00 AM - PR Newswire

Endo International plc Announces Pricing of Private Offering Of Senior Notes
6/25/2014 10:08:00 PM - PR Newswire

Endo International plc Announces Proposed Private Offering Of Senior Notes
6/25/2014 7:30:00 AM - PR Newswire

Elsevier Announces New Reference Module in Biomedical Sciences That Unlocks Current Foundational Content
6/25/2014 4:00:00 AM - Business Wire

Elsevier Chosen to Publish American Dental Association's Flagship Journal
6/24/2014 10:00:00 AM - PR Newswire

Endo to Acquire DAVA Pharmaceuticals
6/24/2014 9:10:00 AM - PR Newswire